Patents by Inventor Shohei OUCHI

Shohei OUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11958952
    Abstract: Provided are a surface-treated glass cloth capable of enhancing insulation reliability when used to prepare a prepreg, a prepreg and a printed wiring board using the surface-treated glass cloth. The surface-treated glass cloth includes a surface treatment layer on a surface, a glass constituting the glass cloth has a composition containing 52.0 to 60.0 mass % of SiO2, 15.0 to 26.0 mass % of B2O3, 9.0 to 18.0 mass % of Al2O3, 1.0 to 8.0 mass % of MgO, 1.0 to 10.0 mass % of CaO, 0 to 6.0 mass % of SrO, 0 to 6.0 mass % of TiO2, and 0.1 to 3.0 mass % in total of F2 and Cl2, based on the total amount of the glass, the glass cloth has a surface coverage of 75.0 to 100.0% and a thickness of 8 to 95 ?m, and the surface treatment layer contains a silane coupling agent having a methacrylic group and contains no surfactant.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: April 16, 2024
    Assignee: Nitto Boseki Co., Ltd.
    Inventors: Hiromitsu Miyagi, Kazutaka Adachi, Atsushi Ouchi, Shohei Iwasawa
  • Publication number: 20210315892
    Abstract: A therapeutic agent for treating at least one disease selected from the group consisting of inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases, comprising: at least one selected from the group consisting of a compound represented by the following general formula (1) and pharmacologically acceptable salts thereof as an active ingredient. [In the formula (1), R1 and R2 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxyl group, a carboxy group, a cyano group, an optionally substituted C1-6 alkyl group et al.; R3 represents a hydrogen atom; R4 represents an optionally substituted 4- to 10-membered monocyclic heterocyclic group containing 1 to 4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by the following formula: —CH2—, —CH2—CH2—, —CH2—CH2—CH2—, or —CH2—O—CH2—; and Z represents a hydrogen atom or a hydroxyl group.
    Type: Application
    Filed: June 27, 2019
    Publication date: October 14, 2021
    Applicant: MEIJI SEIKA PHARMA CO., LTD.
    Inventors: Natsuki ISHIDA, Yuji TABATA, Takashi MATSUHIRA, Keiji TAMURA, Takeru YAMAKAWA, Satoshi ISSHIKI, Yoshinari WAKIYAMA, Shohei OUCHI
  • Patent number: 10669283
    Abstract: A compound represented by the general formula (1) below or a pharmacologically acceptable salt thereof: [In the formula (1), R1 and R2 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxyl group, a carboxy group, a cyano group, an optionally substituted C1-6 alkyl group et al.; R3 represents a hydrogen atom; R4 represents an optionally substituted 4- to 10-membered monocyclic heterocyclic group containing 1 to 4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by the following formula: —CH2—, —CH2—CH2—, —CH2—CH2—CH2—, or —CH2—O—CH2—; and Z represents a hydrogen atom or a hydroxyl group].
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: June 2, 2020
    Assignee: MEIJI SEIKA PHARMA CO., LTD.
    Inventors: Keiji Tamura, Takeru Yamakawa, Satoshi Isshiki, Yoshinari Wakiyama, Shohei Ouchi, Takashi Matsuhira, Natsuki Ishida, Yuji Tabata
  • Publication number: 20190322686
    Abstract: A compound represented by the general formula (1) below or a pharmacologically acceptable salt thereof: [In the formula (1), R1 and R2 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxyl group, a carboxy group, a cyano group, an optionally substituted C1-6 alkyl group et al.; R3 represents a hydrogen atom; R4 represents an optionally substituted 4- to 10-membered monocyclic heterocyclic group containing 1 to 4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by the following formula: —CH2—, —CH2—CH2—, —CH2—CH2—CH2—, or —CH2—O—CH2—; and Z represents a hydrogen atom or a hydroxyl group.
    Type: Application
    Filed: December 26, 2017
    Publication date: October 24, 2019
    Applicant: MEIJI SEIKA PHARMA CO., LTD.
    Inventors: Keiji TAMURA, Takeru YAMAKAWA, Satoshi ISSHIKI, Yoshinari WAKIYAMA, Shohei OUCHI, Takashi MATSUHIRA, Natsuki ISHIDA, Yuji TABATA